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Abstract
p38 mitogen-activated protein kinase (MAPK) is thought to play a central role in acute and chronic inflammatory responses.
Whether p38MAPK plays a pathogenic role in crescentic GN (GN) and which of its four isoforms is preferentially involved in
kidney inflammation is not definitely known. We thus examined expression and activation of p38MAPK isoforms during anti-
glomerular basement membrane (GBM) nephritis. Therefore, p38a conditional knockout mice (MxCre-p38aD/D) were used to
examine the role of p38a in anti-GBM induced nephritis. Both wild type and MxCre-p38aD/D mice developed acute renal
failure over time. Histological examinations revealed a reduced monocyte influx and less tubular damage in MxCre-p38aD/D
mice, whereas glomerular crescent formation and renal fibrosis was similar. Likewise, the levels of pro- and anti-
inflammatory cytokines such as TNF, IL-1 and IL-10 were similar, but IL-8 was even up-regulated in MxCre-p38aD/D mice. In
contrast, we could detect strong down-regulation of chemotactic cytokines such as CCL-2, -5 and -7, in the kidneys of
MxCre-p38aD/D mice. In conclusion, p38a is the primary p38MAPK isoform expressed in anti-GBM nephritis and selectively
affects inflammatory cell influx and tubular damage. Full protection from nephritis is however not achieved as renal failure
and structural damage still occurs.
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Introduction
The MAPK family comprises a large group of protein kinases
that respond for example to growth factors, osmotic stress,
ultraviolet light and cytokines to regulate cell proliferation,
differentiation and apoptosis [1–4]. MAPK regulate three major
pathways: the Jun N-terminal kinases (JNKs), the extracellular
signal-related kinases (ERKs) and the p38 MAPKs [5]. The
p38MAPK pathway was initially identified in macrophages
stimulated with lipopolysaccharide (LPS) and is present in many
cells and tissues [6,7]. Pro-inflammatory cytokines can stimulate
signal transduction through upstream kinases finally resulting in
the phosphorylation and activation of p38MAPK. In turn,
p38MAPK phosphorylates other kinases such as MAPKAPK2
(MK2) and activating transcription factor 2 (ATF2), which
promote transcription of pro-inflammatory genes [8].
p38MAPKs are represented by four different isoenzymes: p38a,
p38b, p38c and p38d [9–14]. Recently, the in vivo functions of the
four isoenzymes could be partially defined. p38b, p38c and p38d
are activated by distinct stimuli in vitro and are expressed in a more
restricted manner. However, mice deficient in either one of these
isoenzymes do not show a major phenotype [15,16]. In contrast,
p38a plays an important role in tissue homeostasis and is widely
expressed. In fact, p38a-deficient mice are not viable due to
placental defects [17–19]. Recently, the use of mice conditionally
deficient for p38a revealed specific roles of this isoenzyme in
erythropoiesis as well as cardiac and liver regeneration [20].
Besides the developmental and regenerative function of p38a,
a pro-inflammatory role has been proposed based on the
pharmacological inhibition of p38 in several animal models of
acute and chronic inflammation. Neutralization of p38 ameliorates
pro-inflammatory cytokine production and tissue damage in
mouse models of arthritis and other autoimmune disease models
[21–25]. Moreover, p38a inhibitors were successfully used in
a rodent model of crescentic glomerulonephritis (GN) [26,27].
Blockade of p38a was associated with reduction in infiltrating
leukocytes and subsequent tissue damage. However, some of these
previously used p38 inhibitors are not entirely specific for
p38MAPK and block both the a- and b-isoform. Also, such
inhibitors showed only minor and transient efficacy in a clinical
trial in patients with rheumatoid arthritis [28].
Thus, it is yet unclear whether p38a indeed plays a specific role
in crescentic GN and whether its inhibition could emerge as an
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effective treatment for this rapidly progressive autoimmune
disease. In this study, we thus used mice conditionally deleted
for p38a and induced anti-glomerular basement membrane
nephritis (anti-GBM) to test whether p38a is indeed responsible




MxCre-p38aD/D mice and MxCre-p38afx/fx mice (wild type
littermates, genetic background C57Bl/6) were used for the
experiments [20]. The deletion of the floxed alleles was induced by
injecting 13 mg/kg polyinosinic-polycytidylic acid (Sigma-Aldrich)
for 3 times intraperitoneally at week 10 of age. Genotyping of mice
was performed in all mice. (Primers for genotyping are given in
Text S1). All animal experiments were approved by the animal
ethics committee of the government of franconia (permit number
54-2532.1-11/10) and were carried out according to legal
obligations defined by national animal protection laws.
Induction of Anti-glomerular Basement Membrane (GBM)
Glomerulonephritis (GN)
Accelerated anti-GBM GN was induced in MxCre-p38aD/D and
wildtype mice as described previously by Asgeirsdottir et al [29].
Briefly, 11-week-old mice were intraperitoneally immunized with
200 mg of sheep IgG (Sigma-Aldrich) dissolved in complete
Freunds adjuvant. After 6.5 days, mice received an intravenous
injection of sheep anti-mouse GBM antibodies (50 mg/kg) and
200 ng of recombinant mouse tumor necrosis factor a (TNFa) in
a total volume of 200 ml. Mice were sacrificed after indicated time
periods and kidneys were perfused with 0.9% cold sodium chloride
solution. One kidney was fixed in 4% formaldehyde for histology
while the other kidney was divided into 3 parts and snap-frozen in
liquid nitrogen and stored at 280uC for protein and mRNA
analysis.
Blood and Urine Examinations
Blood urea nitrogen (BUN) was measured in serum at days 3, 7
and 14 after inducement of anti-GBM GN. A quantitative
enzymatic colorimetric BUN determination kit (Stanbio Labora-
tory, Boerne, Texas) was used according to the manufacturer’s
protocol. To determine kidney function, mice were placed in
single metabolic cages for 24 h the day before sacrifice. Creatinine
was measured in serum and urine, and creatinine clearance was
calculated according to the following formula: crea[urine] 6
vol[urine]/crea[plasma].
Murine Podocyte Cell Culture
Conditionally immortalized mouse podocyte cell lines were
kindly provided by Prof. Karlhans Endlich (University of
Greifswald). They were isolated from kidneys of Immorto-MouseH
mice (Charles River, St. Louis, MO) and carry a thermosensitive
variant of the SV-40 large T-antigen as a transgene. T-antigen
expression is under control of the H-2Kb promoter and can be
induced by mouse interferon-c (IFNc). Proliferating cells are
cultured under permissive conditions (IFNc) at 33uC. Cells
differentiate within 14 days when grown under non-permissive
conditions (without IFNc) at 37uC 42. Before thawing the cells
a tissue culture flask was coated with collagen from rat tail
(0.1 mg/ml; BD Biosciences, Bedford, MA) in phosphate buffered
saline (PBS) for 1 h at 37uC. Cells were plated and propagated at
33uC in RPMI 1640 medium (Gibco) containing 10% FBS (PAN-
Biotech, Aidenbach, Germany), 100 mg/ml penicillin-streptomy-
cin (Gibco) and 20 U/ml c-interferon (Sigma). For differentiation
growing cells were trypsinized and replated in non-coated flasks in
the medium described above but without IFNc. Cells were used at
a maximum confluence.
To assess p38 MAPK isoform activation, differentiated
podocytes were stimulated with recombinant murine TNFa
(10 ng/ml, Biosource) after starvation for 12 hours. Cells were
stimulated with TNFa for 60, 30, 15, 10, 5 and 0.5 minutes. After
the indicated time points, cells were lysed, lysates were mixed with
26 sample loading buffer (SLB; 4% SDS, 125 mM Tris/HCl
pH 6.8, 10% Glycerol, 100 mM DTT, 0.002% bromphenolblue),
boiled and stored at 220uC until western blot analysis.
Primary Antibodies
The following antibodies were used: rabbit anti-phospho
p38MAPK (1:300; Cell Signaling Technology, Beverly, MA),
rabbit anti-p38MAPK (1:300; Cell Signaling), rabbit anti-
p38MAPKa (1:300; Cell Signaling), rabbit anti-p38MAPKb
(1:300; Abgent, San Diego, CA), rabbit anti-p38MAPKc (1:300;
Cell Signaling), rabbit anti-p38MAPKd (1:300; Abgent), rabbit
anti-phospho MK2 (1:300; Cell Signaling), rabbit anti-MK2
(1:300; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-
phospho ATF-2 (1:300; Cell Signaling), rabbit anti-ATF-2 (1:300;
Santa Cruz), rabbit anti-phospho MKK3/6 (1:300; Santa Cruz),
rabbit anti-MKK3 (1:300; Santa Cruz), rabbit anti-MKK6 (1:300;
Santa Cruz), rabbit anti-bActin (1:400; Sigma-Aldrich, St. Louis,
MO). Antibodies against macrophages (anti-F4/80; 1:100; Ser-
otec), neutrophils (1:300; MorphoSys), T lymphocytes (anti CD3;
1:100; NeoMarkers) and B cells (anti-CD20; 1:100; Sigma) were
used for immunohistochemistry.
Western Blotting
In vitro cultured podocytes were lysed, lysates were mixed with
26SLB, boiled and separated by SDS-PAGE followed by transfer
onto nitrocellulose membrane. After blocking with 106 Tris-
buffered saline (TBS), 0.1% Tween 20 and 5% non fat dry milk,
membranes were incubated with primary antibodies. Appropriate
secondary horseradish peroxidase-conjugated antibodies (Dako,
Glostrup, Denmark) and a chemoluminescent detection system
(Pierce, Rockford, IL) were applied. The phosphorylated MAPKs
were analyzed by normalization to total amount of kinase. For
western blotting analysis of kidneys, protein lysates from frozen
tissues were prepared. Tissues were dissolved in buffer containing
urea (7M), glycerol (10%), SDS (1%), Tris pH 6,8 (10 mM),
phosphatase inhibitors (Sigma) and protease inhibitors (Roche,
Mannheim, Germany). Each piece of tissue was homogenized with
an Ultra Turrax and centrifuged for 15 min with 15.000 g at 4uC
to get rid of tissue debris. The supernatant was transferred and
protein concentration determined (BCA protein assay kit, Pierce).
Western Blotting was performed as described above.
Immunoprecipitation
To determine p38 MAPK isoform phosphorylation in cultured
podocytes and whole kidney tissues, immunoprecipitation was
performed. For precipitation of cells, differentiated growth
arrested podocytes were used after 15 min stimulation with TNFa
(10 ng/ml). Cells were lysed in buffer (NP40 1%, sodium chloride
150 mM, Tris/HCl pH 7,5 25 mM, EDTA 1 mM, EGTA
1 mM, sodium fluoride 1 mM, ß-glycerophosphat 1 mM, sodium
pyrophosphate 2,5 mM, vanadate 1 mM, PMSF 1 mM) for 20
minutes on ice, followed by 10 min centrifugation at 10.000 g at
4uC. After determination of protein concentration, samples were
mixed with 30 ml of immobilized protein A plus sepharose (Pierce)
and antibody against phospho-p38 MAPK (1:50) and incubated at
p38a in Murine Glomerulonephritis
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4uC for 2 h while gently shaking. After 3 washing steps with lysis
buffer (5 min, 1.000 g, 4uC) the pellet was resuspended, boiled in
16 SLB and stored at 220uC. As controls two further
immunoprecipitations were performed: One without lysate (neg-
ative control) and one with an isotype matched control antibody
for phospho-p38 MAPK. Immunoprecipitation of kidney tissue
taken at day 3 after injection of nephrotoxic serum was done by
homogenizing the frozen tissue with an Ultra Turrax in buffer at
4uC as described above with addition of sodium dodecylsulfate
(0.1%). After centrifugation (20 min, 10,000 g, 4uC) the superna-
tant was taken and the same procedure followed as described
above. For western blot analysis each gel pocket was loaded with
the full IP preparation or 50 mg of cell or tissue lysate.
Quantitative Real-time RT-PCR
RNA was isolated from cells and tissue with peqGold TriFast
reagent (Peqlab, Erlangen, Germany). RNA was isolated following
standard laboratory procedures with chloroform and alcoholic
precipitation. Purity was measured by photometery (Eppendorf).
1 mg of RNA was reversely transcribed using MuLV reverse
transcriptase (Darmstadt, Germany) and random hexamer
primers. Quantitative PCR amplifications were performed accord-
ing to manufacturer’s protocol on an ABI Prism 7300 sequence
detection system (Applied Biosystems). Primer sequences are given
in Text S1. The RT2 ProfilerTM PCR Array System (SABios-
ciences, Frederick, MD, USA) for mouse chemokines and
receptors was used to analyze the expression of a focused panel
of genes. To this end we isolated RNA from five wild type and five
MxCre-p38aD/D mice 14 days after induction of anti-GBM induced
nephritis. RNA isolation, cDNA preparation and PCR were done
according to the manufacturers protocol. Thermal cycling was run
in an ABI Prism 7300 sequence detection system (Applied
Biosystems).
Histology
To determine the extent of crescent formation, tubular di-
latation and scarring, paraffin embedded sections were stained
with Sirius red, periodic acid-Schiff reagent (PAS) and hematox-
ylin and eosin (HE). To assess the percentage of crescents, all
glomeruli of a section were counted. Afterwards the ratio of
glomeruli affected by crescents to unaffected glomeruli was
determined. The tubular damage index (0 to 3) was determined
by assessing inflammation, fibrosis, tubular dilatation and tubular
atrophy. Fibrosis scoring was performed semiquantitatively on
Sirius red stained sections by evaluating the extent of fibrotic tissue
vs. normal kidney tissue. All analyses were done with an Olympus
CX41 microscopy and a fence ocular in 2006magnification.
Immunohistochemistry
To determine immune cell infiltration of kidneys, serial sections
(2 mm) of paraffin-embedded murine kidneys were used for
immunohistochemistry. Slides for detection of T cells, neutrophils
and macrophages were pretreated with recombinant protease K
(Roche, Mannheim), whereas B-cell detection required no pre-
treatment. Non-specific binding was blocked by addition of
a mixture (1:1 vol) of 10% goat serum and Roti-Immunoblock
(Carl Roth, Karlsruhe, Germany). Sections were incubated with
primary antibodies for 1 h at room temperature, followed by
30 min incubation with specific biotinylated immunoglobulin
(Vector, Burlingame, CA). Vectastain ABC reagent (Vector) and
3,39-diaminobenzidine (DAB, Sigma-Aldrich) as chromogen were
used for final detection. Sections were counterstained with
haematoxylin was done. Scoring of infiltrated immune cells was
as follows: 20 lens coverages were counted all over the section
(mark and cortex) and indicated in positive cells/mm2.
Statistical Analysis
Results were analyzed for statistical differences either with one-
way ANOVA and Tukeys multiple comparison test or unpaired t-
test. P#0.05 was considered statistically significant. Data are
presented as the mean6SEM.
Results
Selective Activation of p38a during Anti-GBM Nephritis
To determine whether p38MAPK signalling is active during
crescentic GN, we used an established anti-GBM model and
evaluated gene and protein expression during the disease course.
To this end, we immunized mice with sheep IgG and then
challenged the sensitized mice with sheep anti-GBM antibodies in
conjunction with a single TNFa injection as previously described
[29].
To demonstrate the functionality of our model, we performed
histological analysis during different time points. As shown in
Fig. 1A–D, injection of anti-GBM antibodies causes glomerular
inflammation, glomerular crescent formation and tubular damage
during the course of disease. We then analyzed expression of pro-
inflammatory (TNFa, IL-1, IL-8) and anti-inflammatory (IL-10,
TGFb1) cytokines by quantitative real-time PCR (qPCR) to gain
insight into the molecular changes during the inflammatory
response (Fig. 1E). TNFa and IL-1b mRNA were up regulated
during the first 7 days of disease. In contrast, IL-8 was found to be
over-expressed during later stages of disease. We also found early
up-regulation of the counter-regulatory cytokine IL-10 during
anti-GBM induced nephritis. Interestingly, TGFb1 was over-
expressed at late stages of anti-GBM nephritis, which might
correlate to crescent formation occurring at the same time.
We next analyzed the expression and activation of the
p38MAPK pathway in this model. We therefore investigated
early (35 min) and late (14 days) time points after injection of anti-
GBM antibodies. First, we determined expression of the four
known p38MAPK isoforms during the course of disease and could
detect mRNA expression of all four p38MAPK isoforms in kidney
lysates. Expression of all four isoforms was however not different
during the disease course (data not shown). We then performed
Western Blot analysis to confirm these findings. In support of the
mRNA data, we could detect p38a, p38b, p38c and p38d in
kidneys injected with anti-GBM antibodies. In line with results
from qPCR, protein expression remained stable throughout the
observation period (data not shown).
After assuring the expression of p38MAPK isoforms in anti-
GBM induced nephritis, we asked whether the p38MAPK
pathway is active during disease. As shown in Fig. 2, p38MAPK
is phosphorylated and thus active throughout the observation
period of anti-GBM induced nephritis. In addition, we found that
the upstream kinase MKK3/6 and the downstream transcription
factor ATF-2 is also phosphorylated indicating a functional
p38MAPK signalling pathway in inflamed kidneys. To investigate,
which p38MAPK isoform is preferentially activated during anti-
GBM induced nephritis we analyzed the activation status of the
p38MAPK isoforms using an activation-specific anti-phospho
p38MAPK antibody. Interestingly, we found a clear activation of
the a-isoform, but not the other p38MAPK isoforms (Fig. 2).
Thus, p38MAPK is expressed and the only active p38MAPK
isoform during anti-GBM induced nephritis is the a-isoform of
p38.
p38a in Murine Glomerulonephritis
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Pro-inflammatory Cytokine Stimulation Specifically
Activates p38a in Podocytes in vitro
We next investigated whether the p38MAPK pathway is
functional in podocytes in vitro as these cells are critically involved
in experimental nephritis and crescent formation [30,31]. As
described previously, we therefore cultured undifferentiated and
differentiated immortalized podocytes in vitro and stimulated them
with TNFa [32]. Analysis of mRNA abundance of the four p38
MAPK isoforms and up- and downstream kinases revealed
expression of the p38 a and c isoform as well as of MKK3,
MKK6, MK2 and ATF-2 (Fig. S1A–B). These findings were
supported by western blot analyses for the four isoforms (Fig. S1C):
p38MAPK a and c but not b and c were detectable especially in
differentiated podocytes. Next, we stimulated differentiated
podocytes with TNF-a (10 ng/ml) to mimic an inflammatory
condition. Western blot analyzes revealed enhanced signalling as
early as 5 minutes (p-p38) to 10 minutes (p-MK2, p-ATF-2) after
stimulation (Fig. S1D) suggesting that podocytes turn on
p38MAPK signalling within minutes after cytokine exposure.
We then addressed which of the p38MAPK isoform is activated.
Immunoprecipitation using an activation-specific anti-phospho
p38MAPK antibody (Fig. S1E) showed very clearly that only p38a
Figure 1. Functionality of the anti- GBM nephritis model and differential cytokine activation. Periodic acid-Schiff reagent (PAS) stain of
a control kidney (A) and kidneys affected by crescentic GN over time are shown. BC =Bowmans capsule, CL = capillary loop, BM=basement
membrane, Pod=podocyte, U = urinary space. Development of full crescents occurs within 14 days (B–D). Mice were sacrificed at indicated days
(original magnification 206). (E) Expression analyses of pro- (TNFa, IL-1, IL-8) and anti-inflammatory (IL-10, TGFb1) cytokines by qPCR in kidneys of
control mice (white bars) and anti GBM-IgG treated mice (black bars). RNA was isolated from whole kidney lysates. Data are the mean value 6 SEM
(n = 4 for each time point).
doi:10.1371/journal.pone.0056316.g001
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is detectable and thus active. Thus, we conclude that pro-
inflammatory stimuli preferentially activate the a-isoform of
p38MAPK further supporting the use of MxCre-p38aD/D mice in
the anti- GBM induced nephritis model.
Effects of Conditional p38a Deletion on Anti-GBM
Nephritis
First, we determined whether p38-gene deletion is evident in the
p38aD/D transgenic mice [20]. As represented in Fig. 3A there is
a full knockout in tissue like spleen and liver and an approximately
50% deletion in the kidney. This is due to the MxCre-flox model
and confirmed by other studies. Nevertheless this model is suitable
for the investigation of anti-GBM nephritis, because the deletion
occurs in areas, which are of interest in this study, e.g. vascular
endothelium, glomerulus, distal convoluted tubule and collecting
duct [33,34]. We found significant reduction of p38 phosphory-
lation in kidney lysates. In support of these data, downstream
activation of MK2 was also strongly reduced. Indeed other MAP
kinases like ERK and JNK are also activated in this model, but
there is no further regulation detectable in the case of p38aD/D
(Fig. 3B). After p38a deletion, we induced anti-GBM nephritis as
described above. We then determined survival of wild type and
MxCre-p38aD/D mice during the course of nephritis. Unexpectedly,
we found no difference in the survival curve as shown in Fig. 3C.
Also, serum urea levels increased both in wildtype (day 14: mean
66.6618.3 mg/dl) and MxCre-p38aD/D mice (day 14: mean
58.4610.5 mg/dl, p = ns vs. wild type) similarly compared to
healthy mice (Fig. 3D). Creatinine clearance revealed a decrease in
both wildtype (134.4629.70; n= 8) and MxCre-p38aD/D
(97.79616.15; n= 8) mice (Fig. 3E) in contrast to healthy control
mice (195.8641.88; n= 4) suggesting impaired filtration function
of the kidney. Thus, deletion of p38a does not protect from kidney
failure in this nephritis model.
Deletion of p38a Ameliorates Tubular but not Glomerular
Damage during Anti- GBM Nephritis
To determine the effects of the absence of p38a on structural
damage during anti- GBM nephritis, we performed qualitative and
quantitative histological scoring. We first analyzed tubular damage
using a semi-quantitative score (Fig. 4A–C). Interestingly, p38a
deletion significantly diminished tubular damage (mean score
0.660.1, p,0.05) as compared to wildtype mice (mean score
0.960.1). KIM-1 and Vimentin mRNA levels corroborated these
data, as these are also markers of tubular damage (Fig. 4D–E). In
both cases mRNA levels in the knockout mice were significantly
reduced in contrast to wild type mice (KIM-1: wildtype
84.23632.57; n= 4 vs. p38aD/D 2.67561.248; n= 4; Vimentin:
wildtype 2.90060.1732; n = 4 vs. p38aD/D 1.37560.3497; n= 4).
Next, we analyzed glomerular crescent formation semi-quantita-
tively (Fig. 4F–H), revealing that similar amounts of glomeruli
revealed crescent formation in wild type and MxCre-p38aD/D mice
(wild-type: mean 3.361.2% vs. MxCre-p38aD/D: 4.261.5, p = ns).
Likewise, no difference was observed for the fibrotic score (Fig. 4I–
K). A slight tissue remodelling occurred in both wildtype and
MxCre-p38aD/D mice (wild-type: mean 1.460.1 vs MxCre-p38aD/D:
1.660.2, p = ns). Although the glomerular deposition of mouse
IgG is generally very low there is a remarkably decrease in the
p38aD/D group (0.08260.0396; n = 5) in contrast to wildtype mice
(0.2560.035; n= 5; Fig. 4L–N). Thus, deletion of p38a protects
from tubular damage in murine anti-GBM nephritis, whereas
glomerular crescent formation and fibrosis is not affected.
Recruitment of Leukocytes to Kidneys in Anti-GBM
Nephritis is p38a-dependent
We next analyzed the role of p38a in leukocyte recruitment into
the kidneys affected by anti-GBM nephritis. We thus performed
immune phenotyping of leukocytes in kidney sections using
immunohistochemistry and quantitatively scored leukocyte in-
filtration. We first asked whether macrophage infiltration is p38a-
dependent. F4/80 staining to detect macrophages clearly revealed
a prominent infiltration in the kidneys of wildtype mice (mean
155.4658.6 cells/mm2). In contrast, MxCre-p38aD/D mice showed
dramatically lower macrophage numbers (mean 25.763.3 cells/
mm2, p,0.05 vs. wild type; Fig. 5A–C). A similar, although less
strong difference was observed, when we evaluated the invasion of
neutrophils. Whereas wild-type mice showed prominent neutro-
phil infiltration (mean 43.865.5 cells/mm2), this was less severe in
MxCre-p38aD/D mice (mean 26.266.6 cells/mm2, p,0.05 vs. wild
Figure 2. Selective activation of p38a during anti- GBM nephritis. (A) p38MAPK phosphorylation during anti-GBM induced nephritis was
investigated at early (35 min) and late (14 days) time points after disease induction using phospho-specific antibodies (left graph). Control lane shows
no p38 phosphorylation before injection of anti- GBM antibodies. (B) Co-Immunoprecipitation (IP) was used to determine which p38 isoform is
activated during anti- GBM nephritis. Kidney tissue was retrieved three days after induction of glomerulonephritis. IP was performed with buffer only
(2) or with kidney lysates and anti-phospho p38MAPK antibody, or with kidney lysates using an isotype-matched control antibody (Iso). IPs and
positive control lysate (+) were separated by SDS-PAGE, blotted onto nitrocellulose and probed with specific antibodies against p38 isoforms
(arrows). HC: heavy chain of the precipitating antibody (right graph).
doi:10.1371/journal.pone.0056316.g002
p38a in Murine Glomerulonephritis
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type; Fig. 5D–F). We then stained renal sections for B and T cells
with anti-CD19 and anti-CD3 antibodies, respectively. Whereas
we could not detect relevant B cell numbers in renal tissues, we
clearly found T cell infiltration in wildtype mice injected with anti-
GBM antibodies (mean 5.061.5 cells/mm2). In contrast to
macrophages and neutrophils, the number of T cells was not
different among wild type and MxCre-p38aD/D mice (mean
9.162.1 cells/mm2, p= ns vs. wildtype; Fig. 5G–I). These data
indicate that p38a is critical for full activation of the innate
immune response during anti-GBM nephritis.
Inflammatory Gene Expression during Anti-GBM
Nephritis is Partially p38a-dependent
As we have observed a reduced renal influx of macrophages and
neutrophils, we next determined whether the altered recruitment
of leukocytes is associated with a change in the expression of pro-
and anti-inflammatory cytokines in the affected kidneys. We
therefore performed qPCR from renal tissue of wildtype and
MxCre-p38aD/D mice 14 days after injection with anti-GBM
antibodies. Whereas the mRNA expression of the pro-inflamma-
tory cytokines TNF, IL-1b and IL-6 was unaltered by p38a-
deletion, we detected a significant downregulation of IL-8 as well
as up- regulation of IL-12 and IL-18 in p38- deficient mice. In
contrast, the expression of anti-inflammatory cytokines such as IL-
10, IL-13 and TGFb1 was not affected by p38a-deletion (Fig. 6A).
In accordance with the data of macrophage staining, MCP-1
(monocyte chemoattractant protein 1) is clearly downregulated in
MxCre-p38aD/D mice.
Because of the prominent phenotype of MxCre-p38aD/D mice
revealing less macrophage and neutrophil influx as compared to
wildtype mice, we analyzed mRNA expression of chemokines in
more detail. As shown in Fig. 6B-C, chemokines associated with
macrophage attraction were generally strongly down- regulated.
Especially Ccl2, -4, -5 and -8 were massively suppressed in MxCre-
Figure 3. Effects of conditional p38a deletion on anti-GBM nephritis. (A) p38MAPKa deletion is depending on tissue and reaches from 50–
100%. (B) Western blot experiments reveal significant reduction of p38 phosphorylation in kidneys of MxCre-p38aD/D transgenic mice at day 14 after
induction of anti-GBM nephritis. Downstream activation of MK2 is also strongly reduced. Three representative animals are shown in each group. (C)
Survival of wild type and MxCre-p38aD/D mice during anti-GBM nephritis shows no difference (controls n = 10, continuous line; wild type n= 16,
spotted line; MxCre-p38aD/D mice n= 18, dashed line). (D) Serum urea levels in wild-type (day 14: mean 66.61618.33 mg/dl; n = 9) and MxCre-p38aD/D
mice (day 14: mean 58.43610.46 mg/dl, p = ns vs. wild-type; n = 9). (E) Creatinine clearance decreases in both wild type (134.4629.70; n = 8) and
MxCre-p38aD/D (97.79616.15; n = 8) mice.
doi:10.1371/journal.pone.0056316.g003
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Figure 4. Deletion of p38a ameliorates tubular but not glomerular damage during anti-GBM nephritis. (A) Semi-quantitative scoring of
tubular damage. p38a deletion significantly diminishes tubular damage (mean score 0.660.1, p,0.05 vs. control; n = 7) as compared to wild type
mice (mean score 0.960.01; n = 7). Tubules of wild type mice (B) are dilated, whereas tubules of MxCre-p38aD/D (C) mice are still tightly packed. (D)
KIM-1 mRNA level is dramatically increased in wild type mice (wild type 84.23632.57; n = 4 vs. p38aD/D 2.67561.248; n = 4) indicating high tubular
damage. (E) Vimentin shows clear upregulation of its mRNA in wild type mice (2.90060.1732; n = 4) whereas it is reduced nearly to the baseline level
in MxCre-p38aD/D mice (1.37560.3497; n = 4). Dashed line indicates RNA base level of control mice. (F–H) Analysis of crescent formation during anti
GBM nephritis. Similar amounts of glomeruli revealed crescent formation in wild type (n = 6) and MxCre-p38aD/D mice (n = 6) (wild type: mean
3.361.2% vs. MxCre-p38aD/D: 4.261.5, p = ns). (I–K) Fibrotic tissue remodelling occurred in both wild type (n = 7) and MxCre-p38aD/D mice (n = 7) (wild-
type: mean 1.40960.1132 vs MxCre-p38aD/D: 1.61560.1617, p = ns). Sirius red staining was performed 14 days after induction of anti-GBM nephritis.
(L–M) p38a deletion affects the immune response to sheep IgG by decreased murine IgG depositions in the glomeruli.
doi:10.1371/journal.pone.0056316.g004
Figure 5. Recruitment of leukocytes to kidneys in anti-GBM nephritis is p38a-dependent. (A–C) F4/80 staining to detect macrophages
clearly reveals a prominent infiltration in the kidneys of wild-type mice (mean 155.4658.6 cells/mm2), whereasMxCre-p38aD/Dmice show dramatically
reduced macrophage numbers (mean 25.763.3 cells/mm2, p,0.05 vs. wild type). (D–F) Wild type mice show prominent neutrophil infiltration (mean
43.865.5 cells/mm2). There is a similar infiltration but less severe in MxCre-p38aD/D mice (mean 26.266.6 cells/mm2, p,0.05 vs. wild type). (G–I) In
contrast to the other lymphocytes the number of T cells is not different among wild type (mean 5.061.5 cells/mm2) and MxCre-p38aD/D mice (mean
9.162.1 cells/mm2, p =ns vs. wild-type). Staining was performed 14 days after induction of anti-GBM nephritis (n = 7/group).
doi:10.1371/journal.pone.0056316.g005
p38a in Murine Glomerulonephritis
PLOS ONE | www.plosone.org 8 February 2013 | Volume 8 | Issue 2 | e56316
p38aD/D mice. We also found that chemokines attracting
neutrophils such as Cxcl1, -4, -5 and IL-8 were down regulated
by p38a during anti-GBM nephritis. However, we could not
detect such general changes regarding chemokines associated with
lymphocyte influx (Fig. 6D). Taken together these data suggest
that p38a deletion selectively blocks the expression of certain
chemokines during anti-GBM nephritis, which are important for
mononuclear cell influx to inflammatory sites. Despite these
findings, pro-inflammatory cytokine production is not dramatically
altered in these mice.
Discussion
The p38MAPK family consists of four isoforms (p38a, p38b,
p38c and p38d) and it has so far been largely unknown, which of
these isoform is expressed and activated in renal inflammation.
Our results indicate that the a-isoform is the most important one
since we demonstrated only significant p38a activation during
anti-GBM induced nephritis in vivo, while the other three p38
isoforms were not activated. In this study, we demonstrate
accordingly a specific role of p38a in an experimental model of
anti-GBM nephritis. Importantly, we demonstrate a preferential
activation of p38a but not other p38 isoforms during the course of
anti-GBM nephritis. Conditional deletion of p38a partially
inhibited renal damage associated with anti-GBM nephritis by
blocking leukocyte influx and tubular damage, while glomerular
crescent formation and renal fibrosis were not affected.
Several lines of evidence suggested an important role for the
p38MAPK pathway in the pathogenesis of crescentic GN: (i)
p38MAPK is expressed and activated in an established rat model
of crescentic GN [35]. These data have been further supported by
expression studies in human biopsies containing various forms of
crescentic GN including ANCA-associated GN [36]. Recent data
also proved the expression and activation of downstream kinase
MK2 in ANCA-associated GN further suggesting a functional
pathway in vivo [36]. (ii) Phosphorylation and thus activation of
p38MAPK occurs at sites of renal damage. Thus, immunohisto-
chemical studies revealed active p38MAPK in podocytes, glomer-
ular crescents, interstitial mononuclear infiltrates and tubular
epithelial cells. In addition, the localization and extent of
p38MAPK activation correlates with renal injury [37]. (iii)
p38MAPK inhibitors have been successfully used in a rat
crescentic GN model [27].
Inhibition of p38MAPKa and b with a small molecule inhibitor
in a rat model of anti-GBM induced nephritis ameliorated both
acute renal failure, proteinuria and leukocyte influx [38].
Sheryanna and colleagues confirmed these results showing, that
p38MAPKa/b inhibition results in reduced renal expression of
adhesion molecules and chemokines [27]. A concern about the
inhibitors used in these studies is, however, their specificity. The
applied compounds usually block both the a - and the b -isoform
of p38MAPK and sometimes also affect non-p38MAPK, such as
JNK3 [39].
Interestingly, overall survival and glomerular crescent formation
were not significantly reduced in the absence of p38a. This is
surprising, because p38MAPK is considered as crucial for acute
inflammatory responses and, for instance, immune responses to
LPS are highly dependent on intact p38MAPK signalling [40].
One explanation could be that other signalling pathways may
substitute for p38a. This hypothesis is supported by the clinical
Figure 6. Inflammatory gene expression during anti-GBM nephritis is partially p38a dependent. qPCRs from renal tissue of wild-type
and MxCre-p38aD/D mice 14 days after injection with anti-GBM antibodies. There is no difference in the mRNA expression of pro-inflammatory
cytokines like TNF, IL-1b and IL-6. Furthermore there is a significant regulation of IL-8, IL-12 and IL-18. There are no significant changes in anti-
inflammatory cytokines like IL-10, IL-13 and TGFb1. MCP-1 is down-regulated in MxCre-p38aD/D mice. n = 4/group measured in duplicates (A).
Leukocyte infiltration is regulated by corresponding chemokines: Chemokines participating in (B) macrophage and (C) neutrophil
recruitment are remarkably downregulated in MxCre-p38aD/D mice. (D) Chemotactic regulation of T cells is unaffected in MxCre-p38aD/D mice. In each
group the RNA of five mice was pooled and then analyzed by RT-PCR with a RT2 ProfilerTM PCR Array kit. mRNA expression was normalized to beta-
actin of wildtype mice.
doi:10.1371/journal.pone.0056316.g006
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data from p38MAPK inhibition in rheumatoid arthritis (RA)
patients [28]. RA patients did show a transient decrease of
inflammatory parameters but relapsed soon after the initiation of
p38 inhibitor therapy. It was also shown that p38a deficiency
could lead to increased NF-kB activation upon pro-inflammatory
stimulation, which may rescue some of the effects elicited by p38
signalling [25].
We did not study the effect of p38a inhibition in other cell types
involved in glomerular injuries such as mesangial and endothelial
cells in vitro. In the latter, deletion of p38a may cause other effects
in inflammatory pathways than in podocytes. Moreover, podo-
cytes in vivo may react different to inflammatory stimuli in terms
of p38 isoform activation than in an artificial in vitro culture
system, which should be addressed in future studies. Alternatively,
p38a may not be of major importance for glomerular in-
flammation and scarring. Indeed, recent evidence proves against
a major role of p38 in the pathogenesis of rodent ANCA-
mediated glomerulonephritis [41].
An explanation for the selective phenotype induced by p38a-
deletion in anti-GBM induced glomerulonephritis emerges when
looking more closely at the histological changes in the kidneys and
cytokine expression profiling. Whereas glomerular crescent
formation and interstitial scarring were not affected by p38a-
deletion, suggesting that the fibrotic response in the anti-GBM GN
model is not dependent on p38a, a significant amelioration of
tubular damage was observed by us. The latter is in agreement
with previous studies using p38 inhibitors [27]. Reduced tubular
damage was associated with reduced leukocyte migration into the
kidneys. Especially macrophage and neutrophil infiltration was
significantly reduced, while T cell infiltration was comparable to
wild type mice injected with anti-GBM antibodies.
Interestingly, p38a is the dominant p38MAPK isoform
expressed and activated in macrophages and podocytes, which
are regarded as crucially involved in the pathogenesis of crescentic
glomerulonephritis. Moreover, we could not detect any reduction
of renal expression of several pro- and anti-inflammatory cytokines
such as TNF, IL-1, IL-6, IL-10 and TGFb1. In contrast, we could
even detect increases in renal mRNA expression of IL-12 and IL-
18 indicating that p38a over time may also have a regulatory
activity to limit inflammation in addition to its well-known pro-
inflammatory role.
The reduced macrophage and neutrophil immigration into
inflamed kidney tissue could be due to different chemokine
expression. In fact, while chemokines responsible for lymphocyte
influx were not generally altered, we could detect massive down-
regulation of macrophage and neutrophil- attracting chemokines
such as Ccl2, -4, Cxcl1, -4 and others. The latter finding may
therefore explain the reduced influx of neutrophils and cells of the
monocyte/macrophages into the kidneys during anti-GBM in-
duced nephritis. However, these potentially positive effects did not
translate into a major clinical amelioration of the experimental
model.
In conclusion, p38a deletion selectively reduces inflammatory
cell influx and tubular damage in murine anti-GBM nephritis but
does not affect the formation of glomerular crescents and renal
fibrosis. Consequently, full clinical and histological protection
could not be achieved. Inhibition of p38a may therefore not be
a promising strategy for the treatment for crescentic GN. Future
studies could investigate why crescent formation and renal fibrosis
can occur when macrophage infiltration is virtually absent.
Supporting Information
Figure S1 Pro-inflammatory cytokine stimulation spe-
cifically activates p38a in podocytes in vitro. Analyses of
the mRNA expression of the four 38MAPK isoforms and up- and
downstream kinases in proliferating (A) and differentiated (B)
podocytes reveal expression of the p38 a and c isoform as well as
of MKK3, MKK6, MK2 and ATF2. (C) Western blot analyses of
the four p38MAPK isoforms support the findings of qPCR. (D)
Protein was extracted from TNF-stimulated (10 ng/ml) differen-
tiated podocytes and analysed for p38MAPK pathway activation
using phospho-specific antibodies. (E) Immunoprecipitations (IP)
were performed with buffer only (2) or with kidney lysates and
anti-phospho p38MAPK antibody, or with kidney lysates using an
isotype-matched control antibody (Iso). IPs and positive control
lysate (+) were separated by SDS-PAGE, blotted onto nitrocellu-
lose and probed with specific antibodies against p38 isoforms
(arrows). HC: heavy chain of the precipitating antibody.
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